Status:
COMPLETED
Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness
Lead Sponsor:
Altitude Physiology Expeditions
Collaborating Sponsors:
University of Edinburgh
Conditions:
High Altitude Pulmonary Edema
Acute Mountain Sickness
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether regular oral use of sildenafil citrate can prevent or attenuate high altitude illnesses.
Detailed Description
High altitude pulmonary oedema (HAPE) is a life-threatening non-cardiogenic lung injury precipitated by exaggerated pulmonary hypertension. The incidence of this rapidly progressive illness, among the...
Eligibility Criteria
Inclusion
- Participant in Apex 2 high altitude expedition
Exclusion
- Previous history of high altitude pulmonary edema
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00627965
Start Date
March 1 2003
End Date
February 1 2008
Last Update
March 4 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.